HEATHER MURRAY: Open Payments
NPI 1952956419 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,431 in 50 payments from 19 companies in 2025. Trend: 2023 $1,717 · 2024 $1,306 · 2025 $1,431
Food & beverage: $1,407Education: $24
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $269 |
| Regeneron Healthcare Solutions, Inc. | 10 | $183 |
| Janssen Biotech, Inc. | 4 | $173 |
| Lilly USA, LLC | 5 | $98 |
| Arcutis Biotherapeutics, Inc. | 4 | $86 |
| ABBVIE INC. | 3 | $84 |
| GENZYME CORPORATION | 2 | $84 |
| UCB, Inc. | 3 | $82 |
| Incyte Corporation | 2 | $57 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $55 |
Products named: DUPIXENT, TREMFYA, Rhapsido, Zoryve, RINVOQ, EBGLYSS, Bimzelx, OPZELURA.
Industry payments across NC — which companies pay providers there.
